Lantheus Holdings, Inc. is 2.8x more valuable than Celldex Therapeutics, Inc. by market capitalization ($6.67 B vs $2.35 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LNTH | CLDX |
|---|---|---|
| Market cap | $6.67 B | $2.35 B |
| US-listed rank | #1193 | #1990 |
| Revenue (latest FY) | $1.54B | $1.54M |
| Net income (latest FY) | $233.56M | -$258.76M |
| Net margin | 15.2% | -16748.0% |
| P/E (trailing FY) | 28.6 | - |
| SEC filings | 1,079 | 1,268 |
Lantheus Holdings, Inc. is 2.8x more valuable than Celldex Therapeutics, Inc. by market capitalization ($6.67 B vs $2.35 B).
In their latest fiscal years, Lantheus Holdings, Inc. reported $1.54B in revenue while Celldex Therapeutics, Inc. reported $1.54M.
Full pages: Lantheus Holdings, Inc. and Celldex Therapeutics, Inc., or browse the full rankings.